1. Home
  2. CYTK vs AVAV Comparison

CYTK vs AVAV Comparison

Compare CYTK & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$76.84

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo AeroVironment Inc.

AVAV

AeroVironment Inc.

N/A

Current Price

$193.51

Market Cap

8.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
AVAV
Founded
1997
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
8.6B
IPO Year
2004
2006

Fundamental Metrics

Financial Performance
Metric
CYTK
AVAV
Price
$76.84
$193.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
17
Target Price
$89.26
$316.88
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
05-05-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,368,000.00
N/A
Revenue This Year
$7.37
$135.55
Revenue Next Year
$310.19
$14.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.60
$135.20
52 Week High
$88.31
$417.86

Technical Indicators

Market Signals
Indicator
CYTK
AVAV
Relative Strength Index (RSI) 45.54 68.15
Support Level $73.95 $175.07
Resistance Level $79.66 $200.38
Average True Range (ATR) 2.91 10.40
MACD -0.37 5.42
Stochastic Oscillator 33.77 95.50

Price Performance

Historical Comparison
CYTK
AVAV

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AVAV AeroVironment Inc.

AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.

Share on Social Networks: